apomorphine has been researched along with quinoxalines in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (70.59) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunow, M; Löschmann, PA; Wachtel, H | 2 |
| Argiolas, A; Melis, MR; Stancampiano, R | 1 |
| Supko, DE; Wallace, LJ | 1 |
| Cannon-Spoor, HE; Freed, WJ | 1 |
| Burns, LH; Isacson, O; Sato, K; Wüllner, U | 1 |
| Dodds, WJ; Lang, IM; Sarna, SK | 1 |
| Lamm, MC; Russell, VA; Taljaard, JJ | 1 |
| Dixon, AK; Gull, P; Hoyer, D; Jaton, AL; Markstein, R; McAllister, K; Rüdeberg, C; Urwyler, S | 1 |
| Bedingfield, JB; Calder, LD; Karler, R | 1 |
| Heneka, MT; Klockgether, T; Kunow, M; Löschmann, PA; Schulz, JB; Wachtel, H; Wüllner, U | 1 |
| Chopin, P; Colpaert, FC; Marien, M | 1 |
| Adaikan, PG; Hayes, ES | 1 |
| Acerbo, MJ; Delius, JD; Gargiulo, PA; Krug, I | 1 |
| Chawla, PS; Kochar, MS | 1 |
| Aguiar, JC; Guimarães, FS; Lisboa, SF; Magesto, AC; Resstel, LB | 1 |
| Buyukuysal, S; Coskun, AS; Goktalay, G; Goktalay, T; Kayir, H; Uslu, G; Uzbay, T; Yorgancioglu, A | 1 |
1 review(s) available for apomorphine and quinoxalines
| Article | Year |
|---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
16 other study(ies) available for apomorphine and quinoxalines
| Article | Year |
|---|---|
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamine Agents; Drug Synergism; Ibotenic Acid; Lisuride; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical | 1992 |
Effect of excitatory amino acid receptor antagonists on apomorphine-, oxytocin- and ACTH-induced penile erection and yawning in male rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenocorticotropic Hormone; Aminobutyrates; Animals; Apomorphine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Oxytocin; Penile Erection; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Amino Acid; Yawning | 1992 |
AMPA glutamate receptor activation in the posterior zona incerta inhibits amphetamine- and apomorphine-induced stereotypy.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apomorphine; Dextroamphetamine; Diencephalon; Ibotenic Acid; Injections; Male; Motor Activity; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Neurotransmitter; Stereotyped Behavior | 1992 |
Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Drug Synergism; Lisuride; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Rats; Rats, Wistar; Stereotaxic Techniques; Substantia Nigra | 1992 |
A possible role of AA2 excitatory amino acid receptors in the expression of stimulant drug effects.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Amphetamine; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dibenzocycloheptenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Glutamates; Mice; Motor Activity; Phencyclidine; Quinoxalines; Receptors, Amino Acid; Receptors, Cell Surface; Stereotyped Behavior | 1990 |
Intra-nigra infusion of AMPA attenuates dopamine-dependent rotation in the rat.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Antagonists; Injections; Male; Motor Activity; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Rotation; Stereotyped Behavior; Substantia Nigra; Thalamic Nuclei; Tyrosine 3-Monooxygenase | 1993 |
Pharyngeal, esophageal, and proximal gastric responses associated with vomiting.
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Brimonidine Tartrate; Dogs; Electromyography; Esophagus; Female; Intestine, Small; Male; Models, Biological; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Nerve Block; Pharynx; Quinoxalines; Stomach; Vagus Nerve; Vomiting | 1993 |
Lack of interaction between alpha 2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices.
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Binding, Competitive; Brimonidine Tartrate; Dopamine; Electric Stimulation; Ergolines; GTP-Binding Proteins; Haloperidol; In Vitro Techniques; Male; Nucleus Accumbens; Pergolide; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Signal Transduction; Sulpiride | 1993 |
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Basal Ganglia Diseases; Catalepsy; Cattle; Dopamine Antagonists; Humans; In Vitro Techniques; Limbic System; Male; Mice; Motor Activity; Prolactin; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Dopamine D1; Retina; Sympathectomy, Chemical | 1996 |
Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.
Topics: Amphetamine; Animals; Apomorphine; Cocaine; Diltiazem; Dopamine Agonists; Drug Interactions; Fluoresceins; Male; Mice; Quinoxalines; Stereotyped Behavior | 1996 |
Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Dopamine Agonists; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotation; Stereotyped Behavior | 1997 |
Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Behavior, Animal; Benzofurans; Brimonidine Tartrate; Clonidine; Dopamine Agonists; Idazoxan; Imidazoles; Ligands; Male; Methylphenidate; Oxidopamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Stereoisomerism; Stereotyped Behavior; Substantia Nigra | 1999 |
The effects of 5HT(1) agonists on erection in rats in vivo and rabbit corpus cavernosum in vitro.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Dopamine Agonists; Male; Muscle, Smooth; Penile Erection; Penis; Pressure; Quinoxalines; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 2002 |
Behavioural consequences of nucleus accumbens dopaminergic stimulation and glutamatergic blocking in pigeons.
Topics: Animals; Apomorphine; Behavior, Animal; Columbidae; Discrimination Learning; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Injections; Nucleus Accumbens; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Stereotaxic Techniques; Stimulation, Chemical | 2002 |
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Topics: Animals; Anxiety; Apomorphine; Arachidonic Acids; Bicuculline; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; GABA-A Receptor Antagonists; Male; Maze Learning; Nitric Oxide Synthase; Oxadiazoles; Periaqueductal Gray; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2013 |
Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
Topics: Acoustic Stimulation; Acoustics; Analysis of Variance; Animals; Apomorphine; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Nicotine; Nicotinic Agonists; Prepulse Inhibition; Quinoxalines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Varenicline | 2014 |